Novartis AG

Novartis AG is a leading global pharmaceutical corporation headquartered in Basel, Switzerland, formed in 1996 through the historic merger of Ciba-Geigy and Sandoz. The company focuses on developing and manufacturing innovative medicines across key therapeutic areas including oncology, immunology, neuroscience, and cardiovascular diseases. Operating in over 130 countries, Novartis reaches approximately 300 million patients worldwide with its portfolio of patented treatments and breakthrough medical technologies. Following the strategic spin-off of its generic division, Sandoz, in 2023, the organization has transitioned into a fully focused innovative medicines company dedicated to reimagining medicine and improving global health outcomes.